Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer
NCT01462604
·
clinicaltrials.gov ↗
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
OTHER:
non-drug intervention educational programme
Sponsor
GlaxoSmithKline